Ines Santolini

431 total citations
13 papers, 349 citations indexed

About

Ines Santolini is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Ines Santolini has authored 13 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 7 papers in Psychiatry and Mental health. Recurrent topics in Ines Santolini's work include Neuroscience and Neuropharmacology Research (13 papers), Ion channel regulation and function (7 papers) and Epilepsy research and treatment (7 papers). Ines Santolini is often cited by papers focused on Neuroscience and Neuropharmacology Research (13 papers), Ion channel regulation and function (7 papers) and Epilepsy research and treatment (7 papers). Ines Santolini collaborates with scholars based in Italy, Netherlands and United Kingdom. Ines Santolini's co-authors include Ferdinando Nicoletti, Richard Teke Ngomba, Gilles van Luijtelaar, Giuseppe Battaglia, Valeria Bruno, Francesco Ferraguti, Clementina M. van Rijn, Aleksandra Badura, Federica Mastroiacovo and Ágnes Simonyi and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Cerebral Blood Flow & Metabolism and Epilepsia.

In The Last Decade

Ines Santolini

13 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ines Santolini Italy 10 292 138 109 74 33 13 349
Aaron H. Sheerin Canada 7 276 0.9× 162 1.2× 131 1.2× 78 1.1× 58 1.8× 8 392
Michael D. Hammonds United States 8 182 0.6× 108 0.8× 97 0.9× 76 1.0× 29 0.9× 9 331
Pratyush Suryavanshi United States 8 182 0.6× 119 0.9× 71 0.7× 63 0.9× 14 0.4× 13 321
Sangwook Jung United States 7 347 1.2× 278 2.0× 131 1.2× 70 0.9× 14 0.4× 9 428
Tabasum Hussain Australia 6 201 0.7× 120 0.9× 102 0.9× 49 0.7× 36 1.1× 7 336
Erika Abrial France 9 134 0.5× 82 0.6× 63 0.6× 37 0.5× 28 0.8× 15 281
Michael Lewis United States 11 180 0.6× 147 1.1× 37 0.3× 36 0.5× 34 1.0× 18 425
Dmitry V. Amakhin Russia 13 354 1.2× 188 1.4× 161 1.5× 137 1.9× 20 0.6× 44 458
Olsen Rw United States 11 255 0.9× 169 1.2× 122 1.1× 97 1.3× 10 0.3× 83 422

Countries citing papers authored by Ines Santolini

Since Specialization
Citations

This map shows the geographic impact of Ines Santolini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ines Santolini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ines Santolini more than expected).

Fields of papers citing papers by Ines Santolini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ines Santolini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ines Santolini. The network helps show where Ines Santolini may publish in the future.

Co-authorship network of co-authors of Ines Santolini

This figure shows the co-authorship network connecting the top 25 collaborators of Ines Santolini. A scholar is included among the top collaborators of Ines Santolini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ines Santolini. Ines Santolini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Wall, Mark J., Ines Santolini, Luisa Di Menna, et al.. (2020). Pharmacological activation of mGlu5 receptors with the positive allosteric modulator VU0360172, modulates thalamic GABAergic transmission. Neuropharmacology. 178. 108240–108240. 8 indexed citations
2.
Santolini, Ines, et al.. (2019). Targeting metabotropic glutamate receptors in the treatment of epilepsy: rationale and current status. Expert Opinion on Therapeutic Targets. 23(4). 341–351. 37 indexed citations
3.
Moyanova, Slavianka, Ines Santolini, Domenico Bucci, et al.. (2018). Abnormal Hippocampal Melatoninergic System: A Potential Link between Absence Epilepsy and Depression-Like Behavior in WAG/Rij Rats?. International Journal of Molecular Sciences. 19(7). 1973–1973. 12 indexed citations
4.
Santolini, Ines, Milena Cannella, Pasquale Parisi, et al.. (2017). Alterations in the α2δ ligand, thrombospondin‐1, in a rat model of spontaneous absence epilepsy and in patients with idiopathic/genetic generalized epilepsies. Epilepsia. 58(11). 1993–2001. 7 indexed citations
5.
Santolini, Ines, Gilles van Luijtelaar, Pasquale Parisi, et al.. (2017). The α2δ Subunit and Absence Epilepsy: Beyond Calcium Channels?. Current Neuropharmacology. 15(6). 918–925. 14 indexed citations
6.
Santolini, Ines, et al.. (2016). The anti-absence effect of mGlu5 receptor amplification with VU0360172 is maintained during and after antiepileptogenesis. Pharmacology Biochemistry and Behavior. 146-147. 50–59. 8 indexed citations
7.
Santolini, Ines, Luana Lionetto, Maurizio Simmaco, et al.. (2014). Head-to head comparison of mGlu1 and mGlu5 receptor activation in chronic treatment of absence epilepsy in WAG/Rij rats. Neuropharmacology. 85. 91–103. 27 indexed citations
8.
Santolini, Ines, Clementina M. van Rijn, Francesca Biagioni, et al.. (2012). Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij rats. Neuropharmacology. 66. 330–338. 29 indexed citations
9.
Ngomba, Richard Teke, Ines Santolini, Francesca Biagioni, et al.. (2011). Protective role for type-1 metabotropic glutamate receptors against spike and wave discharges in the WAG/Rij rat model of absence epilepsy. Neuropharmacology. 60(7-8). 1281–1291. 35 indexed citations
10.
Ngomba, Richard Teke, Ines Santolini, T.E. Salt, et al.. (2011). Metabotropic glutamate receptors in the thalamocortical network: Strategic targets for the treatment of absence epilepsy. Epilepsia. 52(7). 1211–1222. 41 indexed citations
11.
Rijn, Clementina M. van, Silvana Gaetani, Ines Santolini, et al.. (2010). WAG/Rij rats show a reduced expression of CB1 receptors in thalamic nuclei and respond to the CB1 receptor agonist, R(+)WIN55,212‐2, with a reduced incidence of spike‐wave discharges. Epilepsia. 51(8). 1511–1521. 48 indexed citations
12.
Moyanova, Slavianka, Federica Mastroiacovo, Lidia Kortenska, et al.. (2010). Protective Role for Type 4 Metabotropic Glutamate Receptors against Ischemic Brain Damage. Journal of Cerebral Blood Flow & Metabolism. 31(4). 1107–1118. 36 indexed citations
13.
Ngomba, Richard Teke, Francesco Ferraguti, Aleksandra Badura, et al.. (2007). Positive allosteric modulation of metabotropic glutamate 4 (mGlu4) receptors enhances spontaneous and evoked absence seizures. Neuropharmacology. 54(2). 344–354. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026